Table 4.

Extent of scientific assessment for full review.

	Mozambique	Namibia	South Africa	Tanzania	Zambia	Zimbabwe
Chemistry, manufacturing and control (CMC) data extensive assessment	✓	✓	✓	✓	✓	✓
Non-clinical data extensive assessment	✘	✘	✓	✓	✓	✓a
Clinical data extensive assessment	✘	✘	✓	✓	✓	✓a
Bioequivalence data extensive assessment	✘	✓	✓	✓	✓	✓
Additional information obtained (where appropriate)
Other agencies internal review reports	✓	✓	✓	✓	✓	✓
Medical and scientific literature	✓	✓	✓	✓	✓	✓

^aFor biosimilar products not approved by a reference agency only.